See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Alan Zajarias

October 29, 2013

Presentation TCT 2013

Case Resolution

Presenter: Antonio Colombo

October 29, 2013

Presentation TCT 2013

Sutureless Surgical Aortic Valves. Any Role in the TAVR Era?

Presenter: Rudiger Lange

October 29, 2013

Presentation TCT 2013

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Presenter: Fumiyuki Otsuka

October 29, 2013

Presentation TCT 2013

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

Presenter: Andreas Baumbach

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: An HCM Patient Three Years After Septal Ablation - What Follow-up Is Needed?

Presenter: Paul Sorajja

October 29, 2013

Presentation TCT 2013

TCT-9. Racial Disparity With On-Treatment Platelet Reactivity In Patients Undergoing Percutaneous Coronary Intervention

Presenter: Iakshmana Pendyala

October 29, 2013

Presentation TCT 2013

Prognostic Impact of Non-Infarct-Related-Artery Chronic Total Occlusion Revascularization in Patients with Acute Myocardial Infarction Treated by Primary Angioplasty

Presenter: Renato Valenti

October 29, 2013

Presentation TCT 2013

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

Presenter: John Puskas

October 29, 2013

Presentation TCT 2013

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

Presenter: Nicolas Dumonteil

October 29, 2013

Advertisement

Slides

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Case Resolution

Sutureless Surgical Aortic Valves. Any Role in the TAVR Era?

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

Case Presentation and Topic Review: An HCM Patient Three Years After Septal Ablation - What Follow-up Is Needed?

TCT-9. Racial Disparity With On-Treatment Platelet Reactivity In Patients Undergoing Percutaneous Coronary Intervention

Prognostic Impact of Non-Infarct-Related-Artery Chronic Total Occlusion Revascularization in Patients with Acute Myocardial Infarction Treated by Primary Angioplasty

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

TCT-120. Need for Permanent Pacemaker Following Implantation of the Repositionable Second-Generation LOTUS™ Device for Transcatheter Aortic Valve Replacement: Results From the...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content